Literature DB >> 24521959

Emergency use of cardiopulmonary bypass in complicated transcatheter aortic valve replacement: importance of a heart team approach.

Eric E Roselli1, Jay Idrees2, Stephanie Mick2, Samir Kapadia2, Murat Tuzcu2, Lars G Svensson2, Bruce W Lytle2.   

Abstract

OBJECTIVES: Transcatheter aortic valve replacement (TAVR) expands options for high-risk patients with aortic stenosis but is complex with life-threatening complications. We describe indications for use of salvage cardiopulmonary bypass (CPB) and assess outcomes.
METHODS: From 2006 to 2011, 303 patients underwent TAVR, and 12 (4%) required emergency CPB. Approach was transapical (9) and transfemoral (3). Mean age was 82±9 years, median Society of Thoracic Surgeons score was 11 and mean gradient was 46±9 mm Hg. Access for CPB was femoral under fluoroscopy. Principal indication for CPB was hemodynamic instability with or without ischemic changes. These resulted from aortic insufficiency (n=5), valve embolization (n=3), coronary malperfusion (n=2), bleeding requiring pericardiocentesis (n=1), and bleeding from ventricular apex (n=1). Additional procedures included valve-in-valve TAVR (n=5), surgical valve replacement (n=3), and coronary intervention (n=2). Additional circulatory support was used in 7 cases: intra-aortic balloon pump (5) and extracorporeal membrane oxygenation (3).
RESULTS: There were 2 hospital deaths. Mean postoperative gradient was 12±9 mm Hg, and median stay was 16 days. There were no myocardial infarctions or renal failure. One patient had stroke with arm weakness, 2 required tracheostomy, and 2 underwent reoperations for bleeding. Median follow-up was 19 months, and there were 5 late deaths.
CONCLUSIONS: Complications during TAVR can be life threatening and may necessitate additional procedures. Expeditious use of CPB support provided by a multidisciplinary heart team optimizes rescue after myocardial collapse.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24521959     DOI: 10.1016/j.jtcvs.2013.12.052

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

Review 1.  New horizons of non-emergent use of extracorporeal membranous oxygenator support.

Authors:  George Makdisi; Peter B Makdisi; I-Wen Wang
Journal:  Ann Transl Med       Date:  2016-02

Review 2.  Use of extracorporeal membranous oxygenator in transcatheter aortic valve replacement.

Authors:  George Makdisi; Peter B Makdisi; I-Wen Wang
Journal:  Ann Transl Med       Date:  2016-08

3.  Use of extracorporeal membrane oxygenation in complicated transcatheter aortic valve replacement.

Authors:  Kyokun Uehara; Kenji Minakata; Naritatsu Saito; Masao Imai; Hiroki Daijo; Taro Nakatsu; Kazuhisa Sakamoto; Kazuhiro Yamazaki; Takeshi Kimura; Ryuzo Sakata
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-02-24

4.  Outcomes of patients requiring extracorporeal membrane oxygenation in transcatheter aortic valve implantation: a clinical case series.

Authors:  Ryosuke Higuchi; Tetsuya Tobaru; Kenichi Hagiya; Mike Saji; Itaru Takamisawa; Jun Shimizu; Nobuo Iguchi; Shuichiro Takanashi; Morimasa Takayama; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2018-05-02       Impact factor: 2.037

5.  Left ventricular ejection fraction is associated with intraoperative circulatory collapse during transcatheter aortic valve implantation.

Authors:  Bo Fu; Shaopeng Zhang; Shilin Dai; Zhigang Guo; Nan Jiang; Jiange Han; Li Yang; Yanwen Shang; Yanhe Ma; Thomas Puehler; Rodrigo Bagur
Journal:  Ann Transl Med       Date:  2021-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.